NSPc1 is a cell growth regulator that acts as a transcriptional repressor of p21Waf1/Cip1 via the RARE element

被引:34
|
作者
Gong, Yanhua
Yue, Jiping
Wu, Xudong
Wang, Xu
Wen, Jianyan
Lu, Lifang
Peng, Xiaozhong [1 ]
Qiang, Boqin
Yuan, Jiangang
机构
[1] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100005, Peoples R China
[2] Peking Union Med Coll, Natl Human Genome Ctr, Beijing 1000005, Peoples R China
[3] Shanghai Genom Inc, Shanghai 201203, Peoples R China
关键词
D O I
10.1093/nar/gkl834
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mammalian polycomb group proteins play an important role in cell cycle control and tumorigenesis. Nervous system polycomb 1 (NSPc1) is a newly identified transcription repressor, highly homologous with PcG protein Bmi-1. In this article, we showed that NSPc1 could promote tumor cell cycle progression and cell proliferation. Semi-quantitative RT-PCR showed that NSPc1 did not affect the expression levels of most Cyclin-depentent kinases (CDK) inhibitors except for p21Waf1/Cip1. Repression activity assays, chromatin immunoprecipitation (ChIP) and DNA pulldown assays all verified that NSPc1 represses the expression of p21Waf1/Cip1 by binding to the (-1357 to -1083) region of the p21Waf1/Cip1 promoter in vivo, and the repression effect is dependent on the retinoid acid response element (RARE element) within the above region of the p21Waf1/Cip1 promoter. Further analysis showed that NSPc1 could compete the RARE element site with RA receptors both in vitro and in vivo. Taken together, our results support the hypothesis that NSPc1 has a positive role in tumor cell growth by down-regulating p21Waf1/Cip1 via the RARE element, which directly connects transcriptional repression of PcGs to CDKIs and RA signaling pathways.
引用
收藏
页码:6158 / 6169
页数:12
相关论文
共 50 条
  • [1] A Novel Evolutionarily Conserved Element Is a General Transcriptional Repressor of p21WAF1/CIP1
    Xu, Weiguo
    Zhu, Qi
    Wu, Zhenghua
    Guo, Hao
    Wu, Fengjuan
    Mashausi, Dhahiri S.
    Zheng, Chengjie
    Li, Dawei
    CANCER RESEARCH, 2012, 72 (23) : 6236 - 6246
  • [2] p21WAF1/CIP1 acts as a brake in osteoblast differentiation
    Bellosta, P
    Masramon, L
    Mansukhani, A
    Basilico, C
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (05) : 818 - 826
  • [3] Transcriptional induction of p21WAF1/CIP1 by cyclic AMP
    Choi, YH
    Lee, SM
    Lee, J
    Poston, J
    Lee, SJ
    Ha, MJ
    Kang, WK
    Nguyen, PM
    Wang, XF
    Kimá, SJ
    Trepel, JB
    MOLECULAR BIOLOGY OF THE CELL, 1998, 9 : 239A - 239A
  • [4] P21Waf1/Cip1 in endothelial cell survival
    Aoudjit, F
    Sévigny, J
    CARDIOVASCULAR RESEARCH, 2004, 61 (04) : 648 - 650
  • [5] P21WAF1/CIP1 is a common transcriptional target of retinoid receptors
    Tanaka, Takemi
    Suh, Kwang S.
    Lo, Angela M.
    De Luca, Luigi M.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (41) : 29987 - 29997
  • [6] The p21WAF1/CIP1 promoter is methylated in rat-1 cells:: Stable restoration of p53-dependent p21WAF1/CIP1 expression after transfection of a genomic clone containing the p21WAF1/CIP1 gene
    Allan, LA
    Duhig, T
    Read, M
    Fried, M
    MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (04) : 1291 - 1298
  • [7] p21WAF1/CIP1 and cancer: A shifting paradigm?
    Gartel, Andrei L.
    BIOFACTORS, 2009, 35 (02) : 161 - 164
  • [8] POST-TRANSCRIPTIONAL REGULATION OF P21WAF1/CIP1 BY P53
    季加孚
    张霁
    焦春雨
    顾晋
    谭立新
    张平
    李培详
    Chinese Journal of Cancer Research, 2001, (02) : 35 - 39
  • [9] p21WAF1/CIP1 selectively controls the transcriptional activity of estrogen receptor α
    Fritah, A
    Saucier, U
    Mester, J
    Redeuilh, G
    Sabbah, M
    MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (06) : 2419 - 2430
  • [10] Detection of p21WAF1/Cip1 in brain metastases
    Ruan, S
    Fuller, G
    Levin, V
    Bruner, JM
    Zhang, W
    JOURNAL OF NEURO-ONCOLOGY, 1998, 37 (03) : 223 - 228